Dear Friend,
This holiday season, I want to take a moment to celebrate all that we have accomplished together in the fight to end cystic fibrosis. Because of people like you, there have been tremendous steps forward in our work to develop treatments, fuel research, and offer support to the CF community.
In 2019, the FDA approved Trikafta™, a highly effective triple-combination therapy that has the potential to treat the underlying cause of CF for more than 90 percent of people with the disease.